Today, the U.S. Food and Drug Administration approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases. Wezlana, like Stelara, is approved...
Newswise — A novel device developed by researchers from Tokyo Institute of Technology, Tokyo Medical and Dental University, and Chiba University in a new study utilizes...
Warning Letters Issued to Two Companies for Illegally Selling Probiotic Products to Treat Diseases in Preterm Infants As part of the U.S. Food and Drug Administration’s...
A detailed image of the bicarbonate transporter AE1 shows how bicarbonate attaches to the protein. This helped the researchers create a drug-like molecule that could stop...
Mount Sinai study is first to document association that had been hypothesized Newswise — Mount Sinai researchers have discovered a link between certain per- and polyfluoroalkyl...
Newswise — Remember when your parents used to say, “Eat your greens, they are good for you”? Well, they were really onto something. Several studies have...
(Family Features) Every year, 350,000 people die from cardiac arrest in the United States. However, hands-on emergency intervention like cardiopulmonary resuscitation – or CPR – from...
Newswise — Two different regions of the brain are critical to integrating semantic information while reading, which could shed more light on why people with aphasia...
(Family Features) Si está inscrito en Medicare, es importante recordar que la Inscripción Abierta de Medicare es hasta el 7 de diciembre de cada año. Es...
New research offers a tantalizing avenue for treating stroke by reprogramming microglia, the main immune cells in the brain, to replace damaged neurons.
